Chapter 14 · Module 3 · Visual Summary
Cerebral blood flow, intracranial pressure, seizure risk, and cardiovascular profiles of inhalational agents
Central Nervous System Effects
All Volatile Agents
Central Nervous System Effects — Comparative Summary
| Agent | Cerebral Blood Flow | Cerebral Metabolic Rate | Intracranial Pressure | Seizure Risk |
|---|---|---|---|---|
| Halothane | Increases (most) | Decreases | Increases (most) | None |
| Isoflurane | Increases (modest) | Decreases (burst suppression at high dose) | Increases (modest; blunted by hyperventilation) | None (antiepileptiform at high dose) |
| Sevoflurane | Increases (modest) | Decreases | Increases (modest) | Rare spike activity — not clinically epileptogenic |
| Desflurane | Increases (intermediate) | Decreases | Increases (intermediate) | None |
| Enflurane | Increases | Decreases | Increases | YES — contraindicated in seizure disorders |
| Nitrous oxide | Modest increase | Slight increase | Modest increase | None (mild anticonvulsant) |
Key tension: All volatile agents reduce cerebral metabolic rate (protective) but also dilate cerebral vessels (raises intracranial blood volume). Hyperventilation counteracts vasodilation. Propofol does neither — preferred in elevated intracranial pressure states.
Monro-Kellie doctrine: Cranial vault is fixed volume. Brain + cerebrospinal fluid + blood = constant. Any increase in intracranial blood volume raises intracranial pressure when compliance is reduced (mass lesion, edema, hydrocephalus).
Cardiovascular Effects
Cardiovascular Profile
Halothane
Cardiovascular Profile
Isoflurane / Sevoflurane
Cardiovascular Profile
Desflurane
Hypoxic pulmonary vasoconstriction: All volatile agents inhibit this reflex → worsens ventilation-perfusion mismatch during one-lung ventilation. Propofol does NOT inhibit hypoxic pulmonary vasoconstriction → preferred for thoracic surgery total intravenous anesthesia.